Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

Abstract:

:Essential thrombocythemia (ET) and primary myelofibrosis (PMF) are chronic diseases characterized by clonal hematopoiesis and hyperproliferation of terminally differentiated myeloid cells. The disease is driven by somatic mutations in exon 9 of CALR or exon 10 of MPL or JAK2-V617F in >90% of the cases, whereas the remaining cases are termed "triple negative." We aimed to identify the disease-causing mutations in the triple-negative cases of ET and PMF by applying whole-exome sequencing (WES) on paired tumor and control samples from 8 patients. We found evidence of clonal hematopoiesis in 5 of 8 studied cases based on clonality analysis and presence of somatic genetic aberrations. WES identified somatic mutations in 3 of 8 cases. We did not detect any novel recurrent somatic mutations. In 3 patients with clonal hematopoiesis analyzed by WES, we identified a somatic MPL-S204P, a germline MPL-V285E mutation, and a germline JAK2-G571S variant. We performed Sanger sequencing of the entire coding region of MPL in 62, and of JAK2 in 49 additional triple-negative cases of ET or PMF. New somatic (T119I, S204F, E230G, Y591D) and 1 germline (R321W) MPL mutation were detected. All of the identified MPL mutations were gain-of-function when analyzed in functional assays. JAK2 variants were identified in 5 of 57 triple-negative cases analyzed by WES and Sanger sequencing combined. We could demonstrate that JAK2-V625F and JAK2-F556V are gain-of-function mutations. Our results suggest that triple-negative cases of ET and PMF do not represent a homogenous disease entity. Cases with polyclonal hematopoiesis might represent hereditary disorders.

journal_name

Blood

journal_title

Blood

authors

Milosevic Feenstra JD,Nivarthi H,Gisslinger H,Leroy E,Rumi E,Chachoua I,Bagienski K,Kubesova B,Pietra D,Gisslinger B,Milanesi C,Jäger R,Chen D,Berg T,Schalling M,Schuster M,Bock C,Constantinescu SN,Cazzola M,Kralovi

doi

10.1182/blood-2015-07-661835

subject

Has Abstract

pub_date

2016-01-21 00:00:00

pages

325-32

issue

3

eissn

0006-4971

issn

1528-0020

pii

blood-2015-07-661835

journal_volume

127

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

    abstract::Seventeen patients with therapy-related myelodysplastic syndrome (t-MDS) or therapy-related acute nonlymphocytic leukemia (t-ANLL) were treated with single-agent high-dose cytarabine (HDAC; 1 to 3 g/m2 every 12 hours for 12 doses). The initial neoplasm was still present in eight patients when t-MDS/t-ANLL developed. F...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Larson RA,Wernli M,Le Beau MM,Daly KM,Pape LH,Rowley JD,Vardiman JW

    更新日期:1988-10-01 00:00:00

  • Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood.

    abstract::Exposed subendothelial collagen acts as a substrate for platelet adhesion and thrombus formation after vascular injury. Synthetic collagen-derived triple-helical peptides, designated collagen-related peptide (CRP), GFOGER, and VWF-III, can specifically engage the platelet collagen receptors, glycoprotein VI and integr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-260778

    authors: Pugh N,Simpson AM,Smethurst PA,de Groot PG,Raynal N,Farndale RW

    更新日期:2010-06-17 00:00:00

  • Perioperative management of patients on chronic antithrombotic therapy.

    abstract::Perioperative management of antithrombotic therapy is a situation that occurs frequently and requires consideration of the patient, the procedure, and an expanding array of anticoagulant and antiplatelet agents. Preoperative assessment must address each patient's risk for thromboembolic events balanced against the ris...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-423228

    authors: Ortel TL

    更新日期:2012-12-06 00:00:00

  • Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables.

    abstract::To define the efficacy of venetoclax with extended follow-up and identify clinical or biological treatment effect modifiers, updated data for previously treated patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) enrolled in 4 early-phase trials were pooled. Rates of response, complete...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2018882555

    authors: Roberts AW,Ma S,Kipps TJ,Coutre SE,Davids MS,Eichhorst B,Hallek M,Byrd JC,Humphrey K,Zhou L,Chyla B,Nielsen J,Potluri J,Kim SY,Verdugo M,Stilgenbauer S,Wierda WG,Seymour JF

    更新日期:2019-07-11 00:00:00

  • Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma.

    abstract::The influence of ligand:receptor affinity on B-cell antigen receptor (BCR)-induced apoptosis in the IgM+ Burkitt lymphoma line, Ramos, was evaluated with a group of affinity-diverse murine monoclonal antibodies (MoAbs) specific for human B-cell IgM. The studies showed not only a minimal affinity threshold for the indu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mongini PK,Liu Q,Vilensky MA,Highet PF,Inman JK

    更新日期:1998-11-15 00:00:00

  • The future of anti-CD20 monoclonal antibodies: are we making progress?

    abstract::The anti-CD20 monoclonal antibody (mAb) rituximab has revolutionized the treatment of B-cell malignancies. This unprecedented success has not only substantially changed the mindset of the clinical community about the ability of mAb to improve outcomes but has catalyzed the interest in the pharmaceutical industry to de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-298356

    authors: Alduaij W,Illidge TM

    更新日期:2011-03-17 00:00:00

  • Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.

    abstract::The duration of immunodeficiency following marrow transplantation is not known. Questionnaires were used to study the infection rates in 72 patients surviving 20 to 30 years after marrow grafting. Furthermore, in 33 of the 72 patients and in 16 donors (siblings who originally donated the marrow) leukocyte subsets were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.13.3505

    authors: Storek J,Joseph A,Espino G,Dawson MA,Douek DC,Sullivan KM,Flowers ME,Martin P,Mathioudakis G,Nash RA,Storb R,Appelbaum FR,Maloney DG

    更新日期:2001-12-15 00:00:00

  • Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.

    abstract::We have previously shown that the plant-derived compound parthenolide (PTL) can impair the survival and leukemogenic activity of primary human acute myeloid leukemia (AML) stem cells. However, despite the activity of this agent, PTL also induces cellular protective responses that likely function to reduce its overall ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-278044

    authors: Hassane DC,Sen S,Minhajuddin M,Rossi RM,Corbett CA,Balys M,Wei L,Crooks PA,Guzman ML,Jordan CT

    更新日期:2010-12-23 00:00:00

  • HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.

    abstract::Hypoxia-inducible factor-1α (HIF1α), a master transcriptional regulator of the cellular and systemic hypoxia response, is essential for the maintenance of self-renewal capacity of normal HSCs. It is still unknown whether HIF1α has a role in survival regulation of leukemia stem cells (LSCs) in chronic myeloid leukemia ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387381

    authors: Zhang H,Li H,Xi HS,Li S

    更新日期:2012-03-15 00:00:00

  • The effect of isoferritins on granulopoiesis.

    abstract::The evidence for a regulatory role of acidic isoferritins on hemopoiesis is not entirely consistent with our knowledge of ferritin biochemistry, and no clear picture of this phenomeonon has emerged. In the present study, we have been unable to confirm a consistent effect of purified heart (acidic), spleen (basic), or ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sala G,Worwood M,Jacobs A

    更新日期:1986-02-01 00:00:00

  • A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin.

    abstract::Interactions between P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) mediate the earliest "rolling" of leukocytes on the lumenal surface of endothelial cells at sites of inflammation. Previously, PSGL-1 has been shown to be the primary mediator of interactions between neutrophils and P-selectin, but studies o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Snapp KR,Ding H,Atkins K,Warnke R,Luscinskas FW,Kansas GS

    更新日期:1998-01-01 00:00:00

  • Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.

    abstract::Diffuse large B-cell lymphoma (DLBCL) consists of at least 2 phenotypic subtypes; that is, the germinal center B-cell-like (GCB-DLBCL) and the activated B-cell-like (ABC-DLBCL) groups. It has been shown that GCB-DLBCL responds favorably to chemotherapy and expresses high levels of BCL6, a transcription repressor known...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-087734

    authors: Ding BB,Yu JJ,Yu RY,Mendez LM,Shaknovich R,Zhang Y,Cattoretti G,Ye BH

    更新日期:2008-02-01 00:00:00

  • TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities.

    abstract::We examined TP53 mutation in 57 patients with myelodysplastic syndrome (MDS) at either the MDS phase or at the terminal leukemic phase using polymerase chain reaction-mediated single-strand conformation polymorphism (PCR-SSCP) analysis. TP53 mutations within exons 5 through 8 were found in seven patients. All these mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kaneko H,Misawa S,Horiike S,Nakai H,Kashima K

    更新日期:1995-04-15 00:00:00

  • Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

    abstract::Activation of Fas antigen, a cell surface receptor molecule, by its ligand results in transduction of a signal for cell death. The Fas system has been implicated in target cell recognition, clonal development of immune effector cells, and termination of the cellular immune response. Fas antigen expression on lymphocyt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maciejewski J,Selleri C,Anderson S,Young NS

    更新日期:1995-06-01 00:00:00

  • Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.

    abstract::Crystallographic structures indicate that gamma-chain residue Asn308 participates in D:D interactions and indeed substitutions of gammaAsn308 with lysine or isoleucine have been identified in dysfibrinogens with impaired polymerization. To probe the role of Asn308 in polymerization, we synthesized 3 variant fibrinogen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4296

    authors: Okumura N,Gorkun OV,Terasawa F,Lord ST

    更新日期:2004-06-01 00:00:00

  • An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.

    abstract::IL-17 and its receptor are founding members of a novel family of inflammatory cytokines. IL-17 plays a pathogenic role in rheumatoid arthritis (RA)-associated bone destruction. However, IL-17 is also an important regulator of host defense through granulopoiesis and neutrophil trafficking. Therefore, the role of IL-17 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-010116

    authors: Yu JJ,Ruddy MJ,Wong GC,Sfintescu C,Baker PJ,Smith JB,Evans RT,Gaffen SL

    更新日期:2007-05-01 00:00:00

  • Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.

    abstract::Progression of cutaneous T-cell lymphoma (CTCL) is associated with profound defects in cell-mediated immunity and depressed production of cytokines, which support cell-mediated immunity. Because we have observed marked defects in interleukin-12 (IL-12) production in CTCL and because IL-12 is critical for antitumor cyt...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Rook AH,Wood GS,Yoo EK,Elenitsas R,Kao DM,Sherman ML,Witmer WK,Rockwell KA,Shane RB,Lessin SR,Vonderheid EC

    更新日期:1999-08-01 00:00:00

  • Gamma heavy chain disease: clinical aspects and characterization of a deleted, noncovalently linked gamma1 heavy chain dimer (BAZ).

    abstract::This report describes the clinical and immunoglobulin features of a patient with gamma heavy chain disease (HCD), who presented with a clinical picture suggestive of an underlying malignancy rather than the usual picture of lymphoma or granulomatous disease. A unique clinical feature was the nearly total replacement o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Faguet GB,Barton BP,Smith LL,Garver FA

    更新日期:1977-04-01 00:00:00

  • MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

    abstract::The most frequently recurring translocations in mucosa-associated lymphoid tissue (MALT) B-cell non-Hodgkin lymphoma, t(11;18)(q21;q21) and t(14;18)(q32; q21), lead to formation of an API2-MALT1 fusion or IgH-mediated MALT1 overexpression. Various approaches have implicated these proteins in nuclear factor kappaB (NF-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2297

    authors: Ho L,Davis RE,Conne B,Chappuis R,Berczy M,Mhawech P,Staudt LM,Schwaller J

    更新日期:2005-04-01 00:00:00

  • Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.

    abstract::We conducted a genome-wide analysis of genes that are regulated by vascular endothelial growth factor (VEGF) in endothelial cells and identified DSCR1 to be most significantly induced. Consistent with an antagonistic function on calcineurin (CnA) signaling, expression of DSCR1 in endothelial cells blocked dephosphoryl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0273

    authors: Hesser BA,Liang XH,Camenisch G,Yang S,Lewin DA,Scheller R,Ferrara N,Gerber HP

    更新日期:2004-07-01 00:00:00

  • Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells.

    abstract::This study reports a lentiviral gene transfer protocol for efficient transduction of adult human peripheral blood (PB)-derived CD34+ NOD/SCID-repopulating cells (SRCs) using vesicular stomatitis virus-G protein (VSV-G)-pseudotyped lentiviruses encoding for enhanced green fluorescence protein (eGFP). Lentiviral stocks ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.2.709

    authors: Scherr M,Battmer K,Blömer U,Schiedlmeier B,Ganser A,Grez M,Eder M

    更新日期:2002-01-15 00:00:00

  • Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector.

    abstract::Gene therapy for hemophilia A requires efficient delivery of the factor VIII gene and sustained protein expression at circulating levels of at least 1% to 2% of normal. Adeno-associated viral type 2 (AAV2) vectors have a number of advantages over other viral vectors, including an excellent safety profile and persisten...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0292

    authors: Scallan CD,Lillicrap D,Jiang H,Qian X,Patarroyo-White SL,Parker AE,Liu T,Vargas J,Nagy D,Powell SK,Wright JF,Turner PV,Tinlin SJ,Webster SE,McClelland A,Couto LB

    更新日期:2003-09-15 00:00:00

  • In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta).

    abstract::Human and rhesus monkey platelets secrete at least two antiheparin proteins: platelet factor 4 (PF4) and low affinity platelet factor 4 (LA-PF4). Neither of these proteins showed species-related antigenic differences. As determined by radioimmunoassay, the levels of PF4 and LA-PF4 antigen per 10(9) monkey platelets am...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Musial J,Niewiarowski S,Edmunds LH Jr,Addonizio VP Jr,Nicolaou KC,Colman RW

    更新日期:1980-10-01 00:00:00

  • Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

    abstract::Advances in immune assessment, including the development of T-cell receptor excision circle (TREC) assays of thymopoiesis, cytokine-flow cytometry assays of T-cell function, and higher-order phenotyping of T-cell maturation subsets have improved our understanding of T-cell homeostasis. Limited data exist using these m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-05-092130

    authors: Komanduri KV,St John LS,de Lima M,McMannis J,Rosinski S,McNiece I,Bryan SG,Kaur I,Martin S,Wieder ED,Worth L,Cooper LJ,Petropoulos D,Molldrem JJ,Champlin RE,Shpall EJ

    更新日期:2007-12-15 00:00:00

  • Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.

    abstract::Endothelial cell prostacyclin (PGI2) inhibits platelet activation by raising platelet cyclic AMP. Previously, platelet activation was also shown to be blocked by plasmin formed by endothelium-derived tissue plasminogen activator (TPA). We have now studied interactions between PGI2 and plasmin in the control of platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schafer AI,Zavoico GB,Loscalzo J,Maas AK

    更新日期:1987-05-01 00:00:00

  • Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.

    abstract::During the course of multiple myeloma (MM), new monoclonal proteins of an isotype distinct from the original clone, referred to as secondary monoclonal gammopathy of undetermined significance (MGUS), have been described. We report on the frequency, characteristics, and outcome of secondary MGUS. Of the 1942 patients w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-349175

    authors: Wadhera RK,Kyle RA,Larson DR,Dispenzieri A,Kumar S,Lazarus HM,Rajkumar SV

    更新日期:2011-09-15 00:00:00

  • Protein S enhances C4b binding protein interaction with neutrophils.

    abstract::Protein S, an inhibitor of coagulation, interacts reversibly with C4b binding protein (C4bBP). The physiologic role of this complex formation remains unknown. In this study we examined the possibility that protein S would facilitate C4bBP binding to the surface of neutrophils where, in turn, this complex could help pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Furmaniak-Kazmierczak E,Hu CY,Esmon CT

    更新日期:1993-01-15 00:00:00

  • A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation.

    abstract::A novel thrombin inhibitor based on single-stranded (ss) deoxynucleotides with the sequence GGTTGGTGTGGTTGG (thrombin aptamer) has been recently discovered. In this study, we tested its efficacy in inhibiting clot-bound thrombin activity and platelet thrombus formation in an ex vivo whole artery angioplasty model. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Li WX,Kaplan AV,Grant GW,Toole JJ,Leung LL

    更新日期:1994-02-01 00:00:00

  • Platelets: connecting clotting and lysis.

    abstract::In this issue of Blood, Whyte et al describe how under flow conditions, phosphatidylserine-expressing platelets modulate the lysis of whole blood clots by providing direct and indirect binding sites for plasminogen. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-03-632158

    authors: Kim PY

    更新日期:2015-04-16 00:00:00

  • Stimulation by cAMP of erythropoietin secretion by an established human renal carcinoma cell line.

    abstract::We used our recently reported stable, transformed human renal carcinoma cell line as a model system to study the role of 3',5'-adenosine monophosphate (cAMP) in erythropoietin secretion. The erythropoietin produced by these cells is both biologically active and immunologically cross-reactive with purified native human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sherwood JB,Burns ER,Shouval D

    更新日期:1987-04-01 00:00:00